-+ 0.00%
-+ 0.00%
-+ 0.00%
Boston Scientific prices USD 3 billion and EUR 4.25 billion senior debt offerings
Share
Listen to the news
Boston Scientific prices USD 3 billion and EUR 4.25 billion senior debt offerings
  • Boston Scientific priced offerings totaling USD 3 billion in Senior Notes and EUR 4.25 billion in Euro Notes.
  • Proceeds will help finance the Penumbra acquisition and related expenses, with unused funds available for general corporate purposes.
  • The offerings are expected to close December 1, 2026, subject to customary closing conditions.
  • Notes excluding Floating Rate Notes face mandatory redemption at 101% of principal, with accrued interest, if specified acquisition conditions are unmet.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611192045PR_NEWS_USPR_____NE03305) on November 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending